History
  • No items yet
midpage
Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals, Inc.
2012 U.S. Dist. LEXIS 6528
| D. Mass. | 2012
Read the full case

Background

  • Plaintiffs Momenta and Sandoz own the '886 and '466 patents related to generic enoxaparin manufacture.
  • Amphastar, IMS, Watson, and Watson Pharma are alleged to infringe those patents and to solicit sale of infringing products in the United States.
  • In July 2010 Momenta/Sandoz began marketing a generic enoxaparin product; FDA approved Amphastar’s generic; Watson issued a press release in 9/2011 planning a Q4 launch.
  • Plaintiffs filed suit on 9/21/2011; a preliminary injunction is in effect and on appeal along with related stay/dissolution rulings.
  • Amended complaint (10/17/2011) added Watson Pharma as a defendant; defendants move to dismiss or transfer the case to the Central District of California.
  • The court address includes personal jurisdiction, venue, and Rule 12(b)(6) challenges, with jurisdictional discovery motions deemed moot.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the court has personal jurisdiction over all defendants Plaintiffs assert Watson has general jurisdiction; Amphastar/IMS have sufficient Massachusetts contacts for specific jurisdiction Watson argues no MA presence; Amphastar/IMS deny MA activities Watson subject to general jurisdiction; Amphastar and IMS subject to specific jurisdiction in MA
Whether venue is proper in Massachusetts and whether transfer is appropriate MA is proper venue given prior filings and forum interests Transfer to CA would be more convenient for defendants Venue proper in MA; transfer denied; forum chosen by plaintiffs maintained
Whether the Hatch-Waxman safe harbor defeats the 12(b)(6) claim Safe harbor does not bar infringement here Safe harbor provides immunity for certain activities Safe harbor does not absolve alleged infringement under 271(g); 12(b)(6) denied
Whether a transfer under 28 U.S.C. § 1404(a) is warranted Massachusetts forum aligns with ongoing proceedings and witnesses California witnesses and activities would be more convenient No transfer; plaintiff's forum maintained

Key Cases Cited

  • 3D Systs., Inc. v. Aarotech Labs., Inc., 160 F.3d 1373 (Fed. Cir. 1998) (tripartite specific jurisdiction analysis)
  • Red Wing Shoe Co., Inc. v. Hockerson-Halberstadt, Inc., 148 F.3d 1355 (Fed. Cir. 1998) (minimum contacts and reasonableness for jurisdiction)
  • J. McIntyre Machinery, Ltd. v. Nicastro, 131 S. Ct. 2780 (U.S. 2011) (purposeful availment and有限 contacts in massachusetts context)
  • World-Wide Volkswagen Corp. v. Woodson, 444 U.S. 286 (1980) (due process and minimum contacts framework)
Read the full case

Case Details

Case Name: Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals, Inc.
Court Name: District Court, D. Massachusetts
Date Published: Jan 19, 2012
Citation: 2012 U.S. Dist. LEXIS 6528
Docket Number: Civil Action No. 11-11681-NMG
Court Abbreviation: D. Mass.